Sanofi is considering acquiring Insmed Inc. to diversify its portfolio as its blockbuster drug Dupixent faces patent expiration. Insmed's strong respiratory products, like Brinsupri and Arikayce, present...
Thailand's SEC is blocking the acquisition of local cryptocurrency exchange Bitget due to compliance concerns, highlighting increased regulatory scrutiny in the crypto market. This decision may deter foreign...